Futura Medical plc (LON:FUM – Get Free Report)’s stock price fell 6.5% on Friday . The company traded as low as GBX 9.22 ($0.12) and last traded at GBX 9.22 ($0.12). 177,817 shares were traded during mid-day trading, a decline of 74% from the average session volume of 686,352 shares. The stock had previously closed at GBX 9.86 ($0.13).
Futura Medical Stock Down 1.6%
The stock’s 50 day moving average is GBX 10.04 and its two-hundred day moving average is GBX 10.60. The company has a market capitalization of £30.23 million, a PE ratio of -8.00 and a beta of 1.25.
About Futura Medical
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Featured Articles
- Five stocks we like better than Futura Medical
- The Basics of Support and Resistance
- 3 Energy Stocks to Gain Exposure to the Carbon Capture Boom
- What is a Death Cross in Stocks?
- AI Glasses to Replace Smartphones? Meta Is Taking Aim at Apple
- Ride Out The Recession With These Dividend Kings
- The Real Reason Ford Stock Is Rallying—Can It Keep Going?
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
